Evaluating the impact of database heterogeneity on observational study results
Clinical studies that use observational databases to evaluate the effects of medical products
have become commonplace. Such studies begin by selecting a particular database, a …
have become commonplace. Such studies begin by selecting a particular database, a …
[PDF][PDF] Evaluating the Impact of Database Heterogeneity on Observational Study Results
D Madigan, PB Ryan, M Schuemie, PE Stang… - 2013 - Citeseer
MATERIALS AND METHODS In the present paper, we sought to isolate the effect of data
source by holding all other aspects of the study design constant. We considered 53 drug …
source by holding all other aspects of the study design constant. We considered 53 drug …
[HTML][HTML] Evaluating the Impact of Database Heterogeneity on Observational Study Results
D Madigan, PB Ryan, M Schuemie… - American Journal of …, 2013 - ncbi.nlm.nih.gov
Clinical studies that use observational databases to evaluate the effects of medical products
have become commonplace. Such studies begin by selecting a particular database, a …
have become commonplace. Such studies begin by selecting a particular database, a …
Evaluating the impact of database heterogeneity on observational study results
D Madigan, PB Ryan, M Schuemie… - American journal …, 2013 - pubmed.ncbi.nlm.nih.gov
Clinical studies that use observational databases to evaluate the effects of medical products
have become commonplace. Such studies begin by selecting a particular database, a …
have become commonplace. Such studies begin by selecting a particular database, a …
Evaluating the impact of database heterogeneity on observational study results.
D Madigan, PB Ryan, M Schuemie… - American Journal of …, 2013 - europepmc.org
Clinical studies that use observational databases to evaluate the effects of medical products
have become commonplace. Such studies begin by selecting a particular database, a …
have become commonplace. Such studies begin by selecting a particular database, a …
[引用][C] Evaluating the Impact of Database Heterogeneity on Observational Study Results
D MADIGAN, PB RYAN, M SCHUEMIE… - American journal of …, 2013 - pascal-francis.inist.fr
Evaluating the Impact of Database Heterogeneity on Observational Study Results CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …
[PDF][PDF] Evaluating the Impact of Database Heterogeneity on Observational Study Results
D Madigan, PB Ryan, M Schuemie, PE Stang… - Am J …, 2013 - researchgate.net
MATERIALS AND METHODS In the present paper, we sought to isolate the effect of data
source by holding all other aspects of the study design constant. We considered 53 drug …
source by holding all other aspects of the study design constant. We considered 53 drug …
Evaluating the impact of database heterogeneity on observational study results.
D Madigan, PB Ryan, M Schuemie, PE Stang… - 2013 - cabidigitallibrary.org
Clinical studies that use observational databases to evaluate the effects of medical products
have become commonplace. Such studies begin by selecting a particular database, a …
have become commonplace. Such studies begin by selecting a particular database, a …
Evaluating the Impact of Database Heterogeneity on Observational Study Results.
D Madigan, PB Ryan, M Schuemie… - American Journal of …, 2013 - search.ebscohost.com
Clinical studies that use observational databases to evaluate the effects of medical products
have become commonplace. Such studies begin by selecting a particular database, a …
have become commonplace. Such studies begin by selecting a particular database, a …
[PDF][PDF] Evaluating the Impact of Database Heterogeneity on Observational Study Results
D Madigan, PB Ryan, M Schuemie, PE Stang… - Am J …, 2013 - academia.edu
MATERIALS AND METHODS In the present paper, we sought to isolate the effect of data
source by holding all other aspects of the study design constant. We considered 53 drug …
source by holding all other aspects of the study design constant. We considered 53 drug …